シアゾリウムとイミダゾリウムを含む人工酵素は,共酵素を真似する
Huanyu Zhao1, Frank W Foss, Ronald Breslow
1Department of Chemistry, Columbia University, New York, New York 10027, USA.
Journal of the American Chemical Society
|September 4, 2008
まとめ
改変されたポリエチレニミンを用いた酵素ミミカーは,ベンゾイン凝縮反応を劇的に加速し,コエンザイムミミカのみより2300~3300倍速い速度を達成します. これらのポリケーション的ミミックは,触媒効率の向上のために強化された結合と安定性を提供します.
科学分野:
- 有機化学 オーガニック・ケミストリー
- カタリシス カタリシス カタリシス
- バイオミメティック・ケミストリー
背景:
- ベンゾイン凝縮は,炭素-炭素結合形成反応の鍵である.
- シアゾリウムおよびイミダゾリウム塩などのコエンザイムミミカーは,この反応の触媒として知られています.
- ベンゾイン凝縮の効率と速度を向上させることは,引き続き関心のある分野です.
研究 の 目的:
- ハイドロフォビックチアゾリウムとイミダゾリウム共酵素ミミカの触媒活性を,改変ポリエチレニミン (PEI) 酵素ミミカと併用して調査する.
- コエンザイム・ミミックス単独と比較して,組み合わせられたシステムによって達成された速度向上を定量化するために.
- 反応中間物質の安定化におけるポリケチオン酵素ミミックの役割を明らかにする.
主な方法:
- ハイドロフォビックチアゾリウムとイミダゾリウム共酵素ミミカの合成と特徴付け.
- 変形ポリエチレニミン (PEI) 酵素ミミカーの調製.
- ベンゾイン凝縮反応の実施は,コエンザイムミミクスを単独で,および改変PEIの存在下で使用します.
- 反応速度と強化因子を決定するための運動分析.
主要な成果:
- コエンザイムミミクと改造されたPEIの組み合わせは,コエンザイムミミク単独よりも2300~3300倍速くベンゾイン濃縮を触媒化する.
- ポリケチオン酵素ミミックは,コエンザイムと基板のための水害性結合ドメインを提供した.
- 反応経路で形成されたアニオン種の静電安定が観察されました.
結論:
- 改造されたポリエチレニミンは,ベンゾイン凝縮のための水性チアゾリウムとイミダゾリウム共酵素ミミックの触媒活性を大幅に高めます.
- 強化された触媒性能は,基板結合と中間安定化におけるポリケチオンミミックの二重の役割に起因する.
- この研究は,高効率のバイオミメティック触媒の開発のための有望なアプローチを示しています.
関連する概念動画
Ribozymes
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Ribozymes can be...
Ribozymes
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Ribozymes can be...
Cofactors and Coenzymes
Enzymes are proteins made of amino acids. The functional group of each constituent amino acid catalyzes a wide variety of chemical reactions via ionic interactions or acid-base reactions. However, amino acids cannot catalyze oxidation-reduction and group transfer reactions and need to be aided by non-protein components called cofactors. Cofactors are also referred to as the chemical teeth of an enzyme.
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
Cofactors and Coenzymes
Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.
Cofactors and Coenzymes
Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.
Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...


